Ad
related to: xenon pharmaceuticals
Search results
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoXenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript February 29, 2024 Xenon...
Is Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Trading At A 39% Discount?
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Xenon Pharmaceuticals fair value estimate...
After losing 5.2% in the past year, Xenon Pharmaceuticals Inc. (NASDAQ:XENE) institutional owners...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Significantly high institutional ownership implies Xenon Pharmaceuticals' stock price...
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Analysts Just Trimmed Their Revenue Forecasts By 10%
Simply Wall St. via Yahoo Finance· 2 years agoMarket forces rained on the parade of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) shareholders today,...
Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...
GuruFocus.com via Yahoo Finance· 3 months agoXenon Pharmaceuticals Inc (NASDAQ:XENE), a clinical-stage biopharmaceutical company, focuses on...
What Does The Future Hold For Xenon Pharmaceuticals Inc. (NASDAQ:XENE)? These Analysts Have Been...
Simply Wall St. via Yahoo Finance· 2 years agoOne thing we could say about the analysts on Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - they aren't...
Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 10 months agoXenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of -4.35% and 100%,...
Xenon Pharmaceuticals (XENE) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo Finance· 1 year agoXenon Pharmaceuticals (XENE) possesses the right combination of the two key ingredients for a likely...
What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock
Zacks via Yahoo Finance· 3 weeks agoXenon Pharmaceuticals (XENE) might move higher on growing optimism about its earnings prospects,...
Xenon Pharmaceuticals' (NASDAQ:XENE) investors will be pleased with their enviable 884% return over...
Simply Wall St. via Yahoo Finance· 2 years agoWe think all investors should try to buy and hold high quality multi-year winners. And we've seen...